Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase I Single Dose-Escalation Safety Study of Human Glucocerebrosidase (prGCD)

This study has been completed.
Sponsor:
Information provided by:
Protalix
ClinicalTrials.gov Identifier:
NCT00258778
First received: November 23, 2005
Last updated: December 4, 2006
Last verified: December 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: January 2006
  Primary Completion Date: No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):